// App-Quantinova.ai

2711 : Diagnostic Accuracy of the Tina-Quant D-Dimer Gen.2 Assay with Age-Adjusted Cut-Off Ranges for Evaluation of Patients with Suspected Deep Vein Thrombosis or Pulmonary Embolism

Researchers

Presenter

  • Thomas Bertsch

Principal Investigators

  • Wilhelm Behringer

  • Sabine Blaschke

  • Richard Body

  • Simon Davidson

  • Anna Rieger

  • Daniel Horner

  • Ulrich Sonner

  • Yuli Sun

  • Lucia Turnes

  • Michael Hoffman

Medical Centers

  • Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, Nuremberg, Germany

  • Centre of Emergency Medicine, Jena University Hospital, Jena, Germany

  • Interdisciplinary Emergency Care Department, University Medical Centre Göttingen, Göttingen, Germany

  • Haematology, Central Manchester Foundation Trust, Manchester, United Kingdom

  • Roche Diagnostics International Ltd, Rotkreuz, Switzerland

  • Roche Diagnostics GmbH, Penzberg, Germany

  • Salford Royal NHS Foundation Trust, Salford, United Kingdom

  • Agent representing Roche Diagnostics GmbH, Penzberg, Germany

Locations

  • Germany

  • United Kingdom

  • Switzerland

Companies

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved